Levine Zurit 4/A

What Happened

• Levine Zurit, SVP of Business Development at Compugen (CGEN), exercised stock options to acquire a total of 3,125 shares on April 10, 2026 (1,125 shares at $0.83 for $933; 2,000 shares at $1.15 for $2,300). On the same day he sold 3,125 shares in the open market at a weighted average price of $2.56, generating approximately $8,013 in proceeds. The filing also lists derivative dispositions of 1,125 and 2,000 shares at $0.00 (reported as derivative disposals).

Key Details

• Transaction date: April 10, 2026.
• Option exercises (code M): 1,125 shares @ $0.83 = $933; 2,000 shares @ $1.15 = $2,300.
• Open-market sale (code S): 3,125 shares @ weighted avg $2.56 = $8,013; reported sale prices ranged $2.50–$2.60 (footnote F2).
• Derivative dispositions: 1,125 and 2,000 shares reported disposed at $0.00 (likely share surrender for exercise costs or tax withholding).
• Notable footnotes: F1 — sale executed under a Rule 10b5-1 trading plan adopted Dec 23, 2025; F3/F4 — vesting schedules for the options described in the filing.
• Shares owned after transaction: not specified in the provided amendment.
• Filing status: This is an amended Form 4 to correct the "Date of Earliest Transaction" from Apr 7 to Apr 10; all other details remain unchanged.

Context

• The sequence (exercise of options followed by a same-day sale of the same number of shares, plus zero-dollar derivative dispositions) is consistent with a cashless exercise or sell-to-cover arrangement rather than an outright purchase intended to increase a holding. The use of a 10b5-1 plan indicates the sale was pre-authorized under a trading plan. These transactions are routine for option exercises and do not, by themselves, indicate insider sentiment.